Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery

LONDON & SAN FRANCISCO–(BUSINESS WIRE)–Causaly, the leading AI platform for biomedical research, closed $60m in Series B funding led by ICONIQ Growth, with participation from Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club. Strategic individuals also participated in the round, including Alex Gorsky (former Chairman and CEO…
Click here to view original post